Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease
NCT06444516 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 188
Last updated 2026-02-18
Summary
The purpose of this study is to evaluate and demonstrate the efficacy and safety of an investigational ocular lubricant formulation in patients with mild to moderate dry eye disease (DED).
Conditions
Interventions
- OTHER
-
FID123300 ocular lubricant
Investigational ocular lubricant
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Principal Investigators
-
Sr. Clinical Trial Lead, Vision Care · Alcon Research, LLC
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-04
- Primary Completion
- 2025-02-07
- Completion
- 2025-02-07
Countries
- United States
Study Locations
More Related Trials
-
Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease
NCT01459588 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop
NCT00243711 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.
NCT06244316 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Management of the Ocular Surface With Preservative-Free Lubricants in Patients With Dry Eye
NCT06162442 ·Status: RECRUITING
-
A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
NCT05411367 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
NCT06544694 ·Status: COMPLETED ·Phase: PHASE3
-
ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT04899518 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
NCT03333057 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease
NCT03492541 ·Status: COMPLETED ·Phase: NA
-
An Observational Study to Assess Next Generation Emulsion Preservative Free Eye Drops (NGE-UD) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)
NCT06443775 ·Status: COMPLETED
-
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01118754 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of FID 114657 on Tear Film Lipid Layer Thickness
NCT00848068 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Physical Effects of Systane(R) Lubricant Eye Drops Compared to Refresh Tears(R) Lubricant Eye Drops
NCT01160133 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients
NCT01276223 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of an Investigational Lubricant Eye Drop on Lipid Layer Thickness
NCT01066988 ·Status: COMPLETED ·Phase: NA
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
NCT01239069 ·Status: COMPLETED ·Phase: PHASE2
-
Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome
NCT01382225 ·Status: COMPLETED ·Phase: PHASE3
-
Study of EBI-005 in Dry Eye Disease (DED)
NCT02405039 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT02242032 ·Status: COMPLETED ·Phase: PHASE1
-
Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery
NCT04711642 ·Status: UNKNOWN ·Phase: PHASE3
-
Tear Film Break-Up Time Evaluation of FID 114657
NCT01023464 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes
NCT03334539 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
NCT03846453 ·Status: COMPLETED ·Phase: PHASE3